Navin Fluorine International
Navin Fluorine International
ChemicalsKey Fundamentals
MidcapSpecialty ChemicalsChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is expected to give good quarter
- Company has delivered good profit growth of 21.4% CAGR over last 5 years
Weaknesses
1- Stock is trading at 10.5 times its book value
Growth Rate
AI Analysis — Bull vs Bear
Navin Fluorine International is a specialty fluorochemicals company with a market capitalisation of about ₹43,720 Cr. Its TTM sales grew 42% and TTM profit grew 124%, and 5-year compounded profit growth is 21%. It trades at a P/E of 55 and 11x book value, and the stock has returned 88% over the past year.
- TTM profit growth of 124% on TTM sales growth of 42% shows strong operating leverage and margins recovering from the recent lows.
- Profit has compounded at 21% over 5 years and 23% over 10 years, a long record of earnings growth through different chemical cycles.
- Last-year ROE of 20% is well above the 3-year average of 14%, a sign that capital efficiency is improving as new capacity starts contributing.
- Sales have compounded at 23% over 5 years and 17% over 10 years, reflecting steady growth in revenue scale.
- The stock's 10-year CAGR of 34% shows it has compounded shareholder value over the long term, backed by 23% 10-year profit growth.
- Near-term earnings momentum looks positive: the company is expected to report a good quarter, which follows TTM profit growth of 124%.
- A market cap of about ₹43,720 Cr places it among the larger listed specialty chemical companies in India, which supports liquidity and institutional participation.
- A P/E of 55 builds in high growth expectations. Any slowdown from the 124% TTM profit growth rate could trigger a de-rating.
- At 10.93–11.1x book value, the price is a large premium to net assets, which leaves little valuation cushion.
- The stock's 1-year return of 88% is far above its 5-year CAGR of 18%, which suggests much of the recent earnings recovery may already be priced in.
- The 3-year average ROE of 14% is below the 10-year average of 17%, so returns dipped in the recent past. Last year's 20% has not yet been sustained over several years.
- Dividend yield is 0.18%, so shareholder returns depend almost entirely on price appreciation rather than income.
- Sales have compounded at 17% over 3 years, much slower than the 42% TTM rate, which points to cyclicality in the fluorochemicals and CDMO businesses.
- Data gaps on ROCE, debt-to-equity and EPS make it hard to check balance-sheet risk after heavy capex. The 5-year stock CAGR of 18% has also lagged the 21% profit CAGR.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY27 profit more than doubles Sep 7
Consolidated net profit rose 108% YoY to ₹243.3 crore in Q1FY27, and revenue grew 44% to ₹1,045.1 crore. Several outlets reported it between Sep 7 and Sep 30.
- Broad-based segment margin expansion Sep 7
Volume growth and wider margins in all three segments (HPP, Specialty Chemicals and CDMO) drove the results, with CDMO and HPP demand the main contributors to the 44% revenue increase.
- Analyst and investor meet Oct 12 Sep 30
Navin Fluorine has scheduled a meeting with analysts and investors on October 12. Management may update guidance on CDMO and specialty demand there.
- ₹44.39 crore large-trade signal Sep 23
About 53,000 shares changed hands on BSE at ₹8,375 per share, worth ₹44.39 crore in total. This is an unconfirmed real-time signal, and buyer and seller identities have not been disclosed.
TL;DR: Navin Fluorine's Q1FY27 was strong: profit rose 108% to ₹243.3 crore and revenue grew 44% to ₹1,045.1 crore, with margins up across HPP, Specialty Chemicals and CDMO. These articles contain no specific headwinds, but after such a sharp rise in earnings the main risks are a high valuation, a tough base for future year-on-year comparisons and the lumpiness of CDMO orders. The trend is improving, and the October 12 analyst meet will be the next test of whether management expects this growth to last.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 491 | 472 | 500 | 602 | 524 | 519 | 606 | 701 | 725 | 758 | 892 | 938 | 1,045 |
| Expenses | 377 | 373 | 424 | 492 | 423 | 411 | 459 | 522 | 519 | 512 | 585 | 617 | 688 |
| Operating Profit | 114 | 98 | 76 | 110 | 100 | 107 | 147 | 179 | 207 | 246 | 308 | 321 | 357 |
| OPM % | 23% | 21% | 15% | 18% | 19% | 21% | 24% | 26% | 29% | 32% | 34% | 34% | 34% |
| Other Income | 8 | 23 | 64 | 13 | 10 | 11 | 10 | 12 | 14 | 18 | -5 | 31 | 35 |
| Interest | 19 | 20 | 18 | 17 | 16 | 14 | 20 | 28 | 30 | 30 | 28 | 29 | 32 |
| Depreciation | 21 | 24 | 25 | 26 | 27 | 28 | 30 | 35 | 35 | 37 | 36 | 41 | 42 |
| PBT | 82 | 77 | 97 | 79 | 68 | 77 | 108 | 127 | 155 | 198 | 238 | 282 | 318 |
| Tax % | 25% | 22% | 20% | 11% | 25% | 23% | 23% | 25% | 24% | 25% | 22% | 25% | 24% |
| Net Profit | 62 | 61 | 78 | 70 | 51 | 59 | 84 | 95 | 117 | 148 | 185 | 213 | 243 |
| EPS in Rs | 12.41 | 12.22 | 15.74 | 14.19 | 10.32 | 11.86 | 16.86 | 19.15 | 23.62 | 28.96 | 36.18 | 41.48 | 47.43 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 592 | 680 | 742 | 913 | 996 | 1,062 | 1,179 | 1,453 | 2,077 | 2,065 | 2,349 | 3,314 | 3,634 |
| Expenses | 519 | 561 | 582 | 693 | 777 | 794 | 870 | 1,098 | 1,527 | 1,666 | 1,816 | 2,232 | 2,402 |
| Operating Profit | 72 | 118 | 159 | 220 | 219 | 268 | 309 | 356 | 550 | 399 | 534 | 1,082 | 1,232 |
| OPM % | 12% | 17% | 21% | 24% | 22% | 25% | 26% | 24% | 26% | 19% | 23% | 33% | 34% |
| Other Income | 29 | 23 | 55 | 88 | 34 | 29 | 94 | 38 | 36 | 107 | 44 | 58 | 80 |
| Interest | 3 | 4 | 3 | 1 | 1 | 2 | 2 | 2 | 28 | 75 | 78 | 118 | 120 |
| Depreciation | 20 | 22 | 30 | 40 | 28 | 37 | 44 | 48 | 63 | 96 | 119 | 149 | 156 |
| PBT | 78 | 116 | 182 | 266 | 224 | 258 | 358 | 344 | 496 | 336 | 380 | 873 | 1,036 |
| Tax % | 26% | 28% | 25% | 32% | 34% | -56% | 31% | 24% | 24% | 19% | 24% | 24% | — |
| Net Profit | 58 | 84 | 137 | 180 | 149 | 409 | 258 | 263 | 375 | 270 | 289 | 664 | 790 |
| EPS in Rs | 11.18 | 17.08 | 27.88 | 36.43 | 30.15 | 82.57 | 52.02 | 53.09 | 75.68 | 54.56 | 58.19 | 129 | 154 |
| Div. Payout % | 29% | 25% | 23% | 27% | 26% | 13% | 21% | 21% | 16% | 27% | 12% | 7% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 578 | 636 | 825 | 974 | 1,063 | 1,402 | 1,624 | 1,834 | 2,175 | 2,373 | 2,616 | 3,964 |
| Borrowings | 61 | 82 | 19 | 13 | 4 | 1 | 25 | 121 | 861 | 1,368 | 1,466 | 1,272 |
| Other Liabilities | 203 | 228 | 324 | 259 | 231 | 215 | 239 | 420 | 484 | 626 | 738 | 1,133 |
| Total Liabilities | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 |
| Fixed Assets | 274 | 375 | 561 | 428 | 430 | 529 | 540 | 556 | 1,646 | 1,875 | 2,736 | 3,324 |
| CWIP | 60 | 20 | 17 | 20 | 39 | 39 | 95 | 742 | 279 | 711 | 355 | 143 |
| Investments | 171 | 170 | 239 | 428 | 427 | 195 | 99 | 118 | 44 | 495 | 480 | 1,229 |
| Other Assets | 346 | 390 | 360 | 380 | 410 | 866 | 1,163 | 969 | 1,561 | 1,296 | 1,259 | 1,683 |
| Total Assets | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1 | 76 | 92 | 169 | 90 | 157 | 237 | 75 | -64 | 750 | 571 | 894 |
| Investing | 3 | -53 | -16 | -136 | -24 | 85 | -237 | -172 | -656 | -1,094 | -511 | -1,235 |
| Financing | -21 | -17 | -67 | -39 | -68 | -81 | -45 | 42 | 658 | 336 | -47 | 344 |
| Net Cash Flow | -17 | 6 | 10 | -6 | -3 | 161 | -45 | -56 | -61 | -8 | 13 | 3 |
| Free Cash Flow | -61 | 58 | -84 | 121 | 29 | 59 | 147 | -501 | -819 | 72 | 4 | 404 |
| CFO/OP | 28 | 87 | 78 | 100 | 74 | 76 | 71 | 43 | 8 | 196 | 122 | 97 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 81 | 68 | 62 | 63 | 75 | 88 | 90 | 99 | 91 | 90 | 83 |
| Inventory Days | 96 | 89 | 136 | 110 | 91 | 127 | 129 | 149 | 197 | 150 | 117 | 121 |
| Days Payable | 113 | 112 | 94 | 92 | 58 | 79 | 77 | 85 | 103 | 122 | 118 | 144 |
| Cash Conversion Cycle | 57 | 57 | 110 | 80 | 96 | 123 | 140 | 154 | 193 | 119 | 89 | 60 |
| Working Capital Days | 39 | 37 | 4 | 43 | 58 | 88 | 113 | 109 | 140 | 45 | 25 | 44 |
| ROCE % | 11% | 17% | 22% | 29% | 21% | 21% | 22% | 19% | 20% | 11% | 11% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Navin Fluorine International insights
64 extracted metrics + investor summaries across FY00–FY27.
Documents
Frequently Asked Questions about Navin Fluorine International
What does Navin Fluorine International Ltd do?
Where is Navin Fluorine International Ltd (NAVINFLUOR) listed?
Which sector does Navin Fluorine International Ltd belong to?
What is the market capitalisation of Navin Fluorine International Ltd?
What is the PE ratio of Navin Fluorine International Ltd?
What is the 52-week high and low of Navin Fluorine International Ltd?
Does Navin Fluorine International Ltd pay dividends?
What is the Return on Equity (ROE) of Navin Fluorine International Ltd?
Company Information
Navin Fluorine International Ltd is primary engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services.[1] Its portfolio includes 50+ fluorinated compounds developed over the years.[2]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NAVINFLUOR.md for Navin Fluorine International Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.